Pentagon Contracts and SpaceX Fever Propel Rocket Lab to Record High, as Valuation Grows 400% in a Year

Rocket Lab shares surged 83% to a record $150.23, fueled by a $90M Space Force contract, $1.3B in SDA deals, and investor speculation ahead of SpaceX's massive IPO.

The space investment landscape is being reshaped by a rare convergence of defense dollars and public-market anticipation, and Rocket Lab has emerged as the biggest beneficiary. The company’s shares soared to an all-time high of $150.23 this week — a 52-week record that caps an 83% monthly surge — as investors priced in both a string of military wins and the gravitational pull of SpaceX’s looming initial public offering.

The catalyst cluster began with a $90 million contract from the U.S. Space Force to design, build and operate two satellites for the Heimdall space-surveillance mission. It marks Rocket Lab’s first geostationary-orbit satellite order, a significant step beyond its traditional low-Earth-orbit focus. The satellites will use the company’s Lightning bus, modified to withstand the radiation and temperature extremes 35,000 kilometers above the Earth. Simultaneously, Rocket Lab passed the System Requirements Review for the Space Development Agency’s Tranche 3 program, a milestone that secures the technical foundation for a $816 million missile-tracking constellation of 18 satellites. With that win, Rocket Lab’s active SDA contracts now exceed $1.3 billion.

Operationally, the company is delivering numbers that justify some of the hype. First-quarter 2026 revenue jumped 63.5% to $200.3 million — the first time above the $200 million threshold — while GAAP gross margin reached 38.2%. The backlog more than doubled to roughly $2.2 billion, and management guided second-quarter revenue in a range of $225 million to $240 million. Five contracts for the upcoming Neutron rocket have already been signed at standard market prices, executives emphasized.

Yet the scale of the rally owes as much to speculation as to fundamentals. SpaceX is targeting a valuation between $1.75 trillion and $2 trillion in its IPO, hoping to raise as much as $80 billion. That benchmark has forced investors to reassess every publicly traded space name, turning stocks like Rocket Lab, AST SpaceMobile (up 68% in the month) and BlackSky Technology (up 54%) into liquid proxies until SpaceX shares become tradable. On Stocktwits, message volume for Rocket Lab jumped 121% in the past month, and a user poll on the most bullish space stock for the next five years put Rocket Lab at 39%, narrowly ahead of AST SpaceMobile at 38%.

The enthusiasm has pushed the stock well beyond what some analysts consider reasonable. Cantor Fitzgerald maintained its Overweight rating but kept a price target of $96 — more than a third below current trading levels. The shares now sit roughly 70% above their 50-day moving average, a sign that contract successes may already be more than fully priced in.

Beneath the price action, Rocket Lab is undergoing a structural transformation. Long known primarily as the operator of the Electron launch vehicle, the company now manages the full lifecycle of satellite missions, from bus production and sensor integration to ground control. This week’s completion of the Motiv Space Systems acquisition adds robotics capabilities, opening the door to autonomous orbital missions and planetary exploration.

The pivotal near-term catalyst remains the Neutron rocket, a medium-lift vehicle scheduled for its first flight in the fourth quarter of 2026. If it launches on schedule, Rocket Lab would become the only Western alternative to SpaceX in the medium-lift segment. Once SpaceX shares actually begin trading, the sector’s dynamics will shift from a collective upward tide to direct comparative valuation — and Rocket Lab will have to prove its worth with hard operating numbers alone.